Problems with pseudomonas.
McLellan
E
E
Tomlin
K
K
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003422:Critical Care; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D024881:Drug Resistance, Bacterial; D006801:Humans; D017053:Infection Control / Q000379:methods*; D007362:Intensive Care Units; D000077731:Meropenem; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*; D013845:Thienamycins / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem